Topic: Biology
Scientists at Helmholtz Munich and Technical University of Munich used artificial intelligence (AI) to design a protein that can deliver medicines, called RNA, into cells more efficiently. They tested over 100 variants and found one that worked particularly well. This breakthrough could lead to new treatments for diseases.
RNA-based therapeutics use RNA as a blueprint that enables cells to produce specific proteins—including proteins that can precisely modify genes. For this to work, the RNA must reach the inside of the cell intact.
Currently, delivery systems used for this purpose have limitations. Researchers are working on new mechanisms that can deliver RNA into cells more efficiently and selectively. A team at the Institute of Stem Cell Research (ISF) and the Institute of Developmental Genetics (IDG) at Helmholtz Munich and the Technical University of Munich constructed an RNA transporter from scratch.
The researchers combined functional protein building blocks with a structural protein designed using generative AI. This protein forms the scaffold of the vehicle and can adopt shapes that do not occur in nature. The team leader, Dr. Christoph Gruber, says they didn't want to recreate nature but design new structures for efficient RNA delivery.
The study tested over 100 variants, and surprisingly, protein structures with non-natural geometries performed particularly well. STV-C8 was the most efficient. This means that a structure that differs markedly from natural viral capsids works well, which is a key finding for the researchers. It demonstrates the potential of using AI to expand the protein design space.
In cell culture, STV-C8 delivered RNA into target cells far more efficiently than virus-like particles and lipid nanoparticles tested. Compared with lipid nanoparticles, its transfection rate was substantially higher; to achieve comparable protein production, STV-C8 required less RNA. The system can also be loaded with different RNA cargoes and directed toward specific target cells.
The team tested whether the approach works in a living organism using animal models. Following intravenous administration in mice, STV-C8 led to expression of the delivered RNA primarily in the lungs; they found no evidence of immunological or toxic side effects. They also loaded STV-C8 with components of the CRISPR/Cas9 system and injected it into the muscle of a pig. There, they succeeded in removing a disease-relevant section of the dystrophin gene.
STV-C8 is still an experimental system. Before it can be used medically, the researchers will need to investigate how the vehicles can be directed specifically to particular cell types and how they distribute throughout the body.
Why It Matters
This breakthrough could lead to new treatments for diseases like Duchenne muscular dystrophy. Indian students should care about this because it shows the potential of AI in medicine and could inspire them to pursue careers in science and research.
Key Facts
- Scientists at Helmholtz Munich and Technical University of Munich used AI to design a protein that can deliver medicines into cells more efficiently.
- The team tested over 100 variants and found one, STV-C8, that worked particularly well.
- STV-C8 delivered RNA into target cells far more efficiently than current methods in cell culture.
- The system was tested in animal models and showed promise for treating diseases like Duchenne muscular dystrophy.
- The researchers will need to investigate how the vehicles can be directed specifically to particular cell types before it can be used medically.
Key Terms
- RNA
- A molecule that serves as a blueprint for cells to produce specific proteins.
- Generative AI
- Artificial intelligence that generates new information or designs, such as the protein structure in this study.
Implications
This breakthrough could lead to new treatments for diseases like Duchenne muscular dystrophy. Indian students should care about this because it shows the potential of AI in medicine and could inspire them to pursue careers in science and research.
Leave a comment